×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CTOR – citius oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CTOR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
08:37 am
ctor
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
Low
Report
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
12/1
01:16 pm
ctor
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) [Yahoo! Finance]
Low
Report
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) [Yahoo! Finance]
12/1
12:00 pm
ctor
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
Low
Report
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
11/25
07:03 pm
ctor
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
Medium
Report
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
11/25
08:00 am
ctor
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
High
Report
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
11/21
08:48 am
ctor
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration [Yahoo! Finance]
High
Report
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration [Yahoo! Finance]
11/21
08:37 am
ctor
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
Medium
Report
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
11/20
01:33 pm
ctor
Citius Oncology (NASDAQ:CTOR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Citius Oncology (NASDAQ:CTOR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/1
05:13 pm
ctor
Form 8-K CITIUS ONCOLOGY, INC. For: Dec 01
High
Report
Form 8-K CITIUS ONCOLOGY, INC. For: Dec 01
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Webb Carol
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Webb Carol
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Czuczman Myron
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Czuczman Myron
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: HOLUBIAK MYRON Z
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: HOLUBIAK MYRON Z
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Smith Robert Joseph
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Smith Robert Joseph
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: MCGRATH DENNIS M
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: MCGRATH DENNIS M
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Bartushak Jaime
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Bartushak Jaime
12/1
04:10 pm
ctor
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Holuka Eugene Myron
High
Report
Form 4/A CITIUS ONCOLOGY, INC. For: Sep 19 Filed by: Holuka Eugene Myron
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: